Bitter melonGlibenclamideType 2 diabeticsGlycemic controlCardiovascular risk factorsObjective Since antiquity bitter melon has been in use for treating diabetes but clinical trials show conflicting results about its usefulness. The present study aims to asses and compare the hypoglycemic and antiatherogenic ...
Glucagon-like peptide-1 (GLP-1), an incretin hormone predominantly synthesized postprandially by enteroendocrine L cells (mainly in the distal small and large intestines), mediates intestinal feedback to limit postprandial glycemic excursions and suppresses energy intake [167]. Several cellular studies ...